Skip to content

Expectations in Rheumatic Diseases

Expectations in Rheumatic Diseases - EXPERD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00024843
Enrollment
150
Registered
2021-03-31
Start date
2021-01-27
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M06 M45

Interventions

Group 1: The patients receive a set of questionnaires with 49 questions at baseline and after 6 and 12 months, which assess various aspects of expectations, attitudes, psychosocial stress and personal

Sponsors

Poliklinik und Funktionsbereich für Rheumatologie und Hiller-Forschungszentrum, Universitätsklinikum Düsseldorf
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis: seropositive and seronegative rheumatoid arthritis, systemic lupus erythematosus, vpondyloarthropathy, inflammatory myositis, systemic vasculitis; > 18 years; written informed consent; sufficient German language skills; longterm care at the recruitment site

Exclusion criteria

Exclusion criteria: insufficient German language skills

Design outcomes

Primary

MeasureTime frame
Disease associated disability (Pain Disability index)

Secondary

MeasureTime frame
Dispositional Optimism (Revised Life Orientation Test); Fear of Progression (Fear of Progression Questionnaire, Short form); Anxiety and Depression (Patient Health Questionnaire & Generalized Anxiety Disorder); Pain (NRS for pain intensity, -burden and -expectation; General patient global assessment of disease severity (NRS 0-10); Functionality (Funktionsfragebogen Hannover) ; Health related Quality of Life (Short Form-12); Fatigue (Fatigue Severity Scale) Disease Activity (Disease specific scores): ; Rheumatoide Arthritis (RA): Disease Activity Score 28, RA disease activity index; Systemic Lupus Erythematosus (SLE): SLE disease activity index, Systemic Lupus Activity Questionnaire; ankylosing spondylitis: Bath Ankylosing Spondylitis Disease Activity Index All questionnaires will be assessed at T0, T1 and T2

Countries

Germany

Contacts

Public ContactJohanna Mucke

Poliklinik, Funktionsbereich und Hiller Forschungszentrum für Rheumatologie Universitätsklinikum Düsseldorf

Johanna.mucke@med.uni-duesseldorf.de02118117817

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026